26. Is There a Correlation Between Reactogenicity and Immune Responses of the Adjuvanted Recombinant Zoster Vaccine (RZV)? A Post-hoc Analysis

BACKGROUND: RZV (GSK) contains the varicella-zoster virus antigen glycoprotein E (gE) and the adjuvant system AS01(B) that enhances gE-specific immune responses through stimulating innate immunity. AS01(B) may contribute to the development of transient local or systemic post-vaccination reactions. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Callegaro, Andrea, Willer, David O, Burny, Wivine, Hervé, Caroline, Kim, Joon Hyung, levin, myron J, Zahaf, Toufik, Cunningham, Anthony L, Didierlaurent, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644461/
http://dx.doi.org/10.1093/ofid/ofab466.228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644461/
http://dx.doi.org/10.1093/ofid/ofab466.228

Ejemplares similares